(131)I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment.
D'Huyvetter, M., De Vos, J., Xavier, C., Pruszynski, M., Sterckx, Y.G.J., Massa, S., Raes, G., Caveliers, V., Zalutsky, M.R., Lahoutte, T., Devoogdt, N.(2017) Clin Cancer Res 23: 6616-6628
- PubMed: 28751451 
- DOI: 10.1158/1078-0432.CCR-17-0310
- Primary Citation of Related Structures:  
5MY6 - PubMed Abstract: 
Purpose: Camelid single-domain antibody-fragments (sdAb) have beneficial pharmacokinetic properties, and those targeted to HER2 can be used for imaging of HER2-overexpressing cancer. Labeled with a therapeutic radionuclide, they may be used for HER2-targeted therapy ...